Studies on the antibacterial activity of the antimicrobial peptide Mastoparan X against methicillin-resistant Staphylococcus aureus
Our study demonstrated that Mastoparan X has potent bactericidal activity against MRSA and is expected to provide new potential peptides for the clinical treatment of MRSA.
Authors
- Xiaofang Liang (ORCID: https://orcid.org/0000-0003-1147-0190)
- Lianhua Wei (ORCID: https://orcid.org/0009-0008-9984-1382)
- Zhangping Lu (ORCID: https://orcid.org/0000-0002-6465-7429)
- Qianqian Liu (ORCID: https://orcid.org/0000-0003-0661-1139)
- Wenjie Wang (ORCID: https://orcid.org/0000-0002-3199-7785)
- Zhihong Liu (ORCID: https://orcid.org/0000-0001-6093-0726)
- Yaozhou Wu
- Yingying Sun (ORCID: https://orcid.org/0000-0003-3156-8347)
- F. Lin (ORCID: https://orcid.org/0009-0005-1766-2873)
- Yu Zhang (ORCID: https://orcid.org/0000-0003-1017-4170)
- Wangjun Deng
- Yulin Wang (ORCID: https://orcid.org/0009-0008-3020-7607)
- Meng Liu (ORCID: https://orcid.org/0000-0002-7759-0681)
Institutions
- Gansu Provincial Hospital (CN)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2025-05-29
- DOI
- https://doi.org/10.3389/fcimb.2025.1552872
- Citations
- 3
- Primary Topic
- Antimicrobial Peptides and Activities
- Type
- article
- Field-Weighted Citation Impact
- 3.55